个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共8条记录   Perioperative safety of aprotinin in coronary artery bypass graft surgery [作者：Augoustides, JG,期刊：Drug safety, 页码：557-560 , 文章类型： Editorial Material，,卷期：2008年31-7] Benefit-risk assessment of telithromycin in the treatment of community-acquired pneumonia [作者：Brown, SD,期刊：Drug safety, 页码：561-575 , 文章类型： Review，,卷期：2008年31-7] The purpose of this review is to assess the benefits and risks associated with the use of the ketolide antibacterial telithromycin, currently licensed for the treatment of adults with mild to moderate community-acquired ... Memantine for the treatment of Alzheimer's disease [作者：Farlow, MR; Graham, SM; Alva, G,期刊：Drug safety, 页码：577-585 , 文章类型： Article，,卷期：2008年31-7] Background: Memantine, a moderate-affinity, uncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, is the first non-cholinergic agent approved for the treatment of Alzheimer's disease (AD), and the first medi... Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors [作者：Molden, E; Skovlund, E; Braathen, P,期刊：Drug safety, 页码：587-596 , 文章类型： Article，,卷期：2008年31-7] Background: Co-administration of cytochrome P450 (CYP) 3A4 inhibitors with simvastatin or atorvastatin is associated with increased risk of developing myopathy or rhabdomyolysis.Objective: To detect co-prescriptions of C... Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression [作者：Ormerod, S; McDowell, SE; Coleman, JJ; Ferner, RE,期刊：Drug safety, 页码：597-607 , 文章类型： Article，,卷期：2008年31-7] Background: Factors such as age, sex and disease state alter a patient's susceptibility to adverse drug reactions (ADRs). Ethnicity may also alter the risk of an ADR.Objective: To review the evidence for ethnic differenc... Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy [作者：Motola, D; Vargiu, A; Leone, R; Conforti, A; Moretti, U; Vaccheri, A; Velo, G; Montanaro, N,期刊：Drug safety, 页码：609-616 , 文章类型： Article，,卷期：2008年31-7] Background: The reporting of adverse drug reactions (ADRs) is the mainstay of post-marketing surveillance systems. Under-reporting and selective reporting are considered the main limitations of a spontaneous reporting-ba... Safety of low-dose aprotinin in coronary artery bypass graft surgery [作者：Kluth, M; Lueth, JU; Zittermann, A; Lanzenstiel, M; Koerfer, R; Inoue, K,期刊：Drug safety, 页码：617-626 , 文章类型： Article，,卷期：2008年31-7] Background: The antifibrinolytic agent aprotinin is used to limit blood loss in cardiac surgery. In a recently performed multicentre observational study, the use of aprotinin was dose-dependently associated with a higher... Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole [作者：Estborn, L; Joelson, S,期刊：Drug safety, 页码：627-636 , 文章类型： Article，,卷期：2008年31-7] Background: A potential causal association between an increase in gastric pH and a risk of community-acquired respiratory tract infection (RTI), specifically pneumonia, has been debated in relation to the use of potent g...